OIG audit targets excessive billing for genetic testing
Between 2016 and 2019, Medicare payments to laboratories for genetic tests quadrupled from $351 million to $1.41 billion. This sharp increase in spending on genetic testing is likely linked to excessive and fraudulent billing, according to a recent Office of Inspector General (OIG) report.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.